Inactivated Polio And Rabies Vaccines Global Market Report 2025

Description

Inactivated polio and rabies vaccines (IPV) are designed to protect individuals from polio and rabies, respectively. Both vaccines are made using viruses that have been inactivated, meaning they cannot cause disease. IPV prevents poliomyelitis, a viral illness that can lead to paralysis, while the inactivated rabies vaccine offers protection against rabies, a fatal infection usually transmitted through animal bites. These vaccines stimulate the immune system to provide long-lasting protection without causing illness.

The primary product types of inactivated polio and rabies vaccines include the inactivated polio vaccine and inactivated rabies vaccine. The inactivated polio vaccine (IPV) is a safe, injectable vaccine derived from inactivated poliovirus, designed to strengthen immunity and protect against polio without causing infection. It is inactivated using various methods, such as the solvent-detergent method, radiation, pH concentration, heat inactivation, and others. The vaccine is distributed through several channels, including both government and private sectors, for use in different populations, such as pediatrics and adults.

The inactivated polio and rabies vaccines market research report is one of a series of new reports from The Business Research Company that provides inactivated polio and rabies vaccines market statistics, including the inactivated polio and rabies vaccines industry global market size, regional shares, competitors with the inactivated polio and rabies vaccines market share, detailed inactivated polio and rabies vaccines market segments, market trends, opportunities, and any further data you may need to thrive in the inactivated polio and rabies vaccines industry. This inactivated polio and rabies vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The inactivated polio and rabies vaccines market size has grown strongly in recent years. It will grow from $2.16 billion in 2024 to $2.30 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth during the historic period can be attributed to factors such as expanding vaccination campaigns, increased awareness about polio and rabies, government immunization programs, high incidence rates of polio and rabies in certain regions, and support from international health organizations.

The inactivated polio and rabies vaccines market size is expected to see strong growth in the next few years. It will grow to $2.88 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth during the forecast period is expected to result from advancements in vaccine technology, the rising demand for vaccination in emerging markets, a heightened focus on global health security, government policies encouraging vaccination, and increased healthcare spending on preventive measures. Major trends during the forecast period include a growing demand for combined polio and rabies vaccines, advancements in freeze-drying technology to enhance vaccine stability, the development of single-dose formulations for easier administration, improvements in cold chain logistics for better vaccine distribution, expansion of global immunization programs, and government-funded vaccination initiatives.

The increasing demand for effective vaccination programs is expected to drive the growth of the inactivated polio and rabies vaccines market. Vaccination programs, organized by governments or organizations to protect people from diseases, are becoming more widespread as governments intensify efforts to prevent outbreaks, reduce healthcare costs, and improve public health. These initiatives contribute to the demand for inactivated polio and rabies vaccines by raising awareness, securing funding, and expanding coverage in high-risk areas. Mass vaccination campaigns and routine immunizations, often led by governments and health organizations, ensure consistent vaccine uptake. For example, in April 2024, the Pan American Health Organization (PAHO) reported that the 22nd Vaccination Week in the Americas (VWA), themed "Engage now to protect your future, GetVax," aimed to boost vaccination coverage in underserved areas by administering over 65 million doses. The initiative also worked to combat misinformation and improve vaccine access through community engagement and tailored campaigns. This growing demand for effective vaccination programs is driving the growth of the inactivated polio and rabies vaccines market.

Companies in the inactivated polio and rabies vaccines market are advancing product development, such as inactivated rabies vaccines, to improve immunogenicity and address the global demand for effective disease prevention. Killed virus rabies vaccines are made using a rabies virus that has been rendered non-infectious through chemical or physical processes. These vaccines stimulate the immune system to produce protective antibodies without causing the disease, making them safe and effective for both pre- and post-exposure use. For example, in April 2024, Sanofi, a UK-based pharmaceutical company, launched Verorab, an inactivated rabies vaccine, in the UK for both pre-exposure and post-exposure prophylaxis of rabies for all age groups. The vaccine, approved in the UK based on extensive clinical data from over 13,000 individuals, has been widely used in over 80 countries. Verorab offers an effective immunization option for travelers to high-risk countries and for rabies post-exposure treatment, with clinical trials showing strong immune responses and long-lasting protection.

In June 2024, Sanofi partnered with Biovac, a South Africa-based biopharmaceutical company, to support local vaccine production in Africa. This collaboration aims to establish sustainable local manufacturing of inactivated polio vaccines (IPV), enhancing regional self-sufficiency and advancing polio eradication efforts across more than 40 African countries. Biovac specializes in developing vaccines for diseases that disproportionately affect people in Africa.

Major players in the inactivated polio and rabies vaccines market are Merck & Co Inc., Sanofi S.A., LG Chem Ltd., Boehringer Ingelheim International GmbH, Sinovac Biotech, Zoetis Inc., Cadila Pharmaceuticals, Zydus Lifesciences Limited, Biological E. Limited, Serum Institute of India (SII), Indian Immunologicals Limited (IIL), Instituto Butantan, Valneva SE, Bio Farma, Bharat Biotech, Bilthoven Biologicals, Panacea Biotec, Batavia Biosciences, Hilleman Laboratories, and China National Pharmaceutical Group Co Ltd.

North America was the largest region in the inactivated polio and rabies vaccines market in 2024. The regions covered in inactivated polio and rabies vaccines report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the inactivated polio and rabies vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The inactivated polio and rabies vaccines market consists of sales of combination vaccines containing inactivated polio vaccine (IPV), pre-exposure prophylaxis vaccines, and post-exposure prophylaxis (PEP) kits. Values in this market are 'factory gate' values, that is, the value of goods sold to the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Inactivated Polio And Rabies Vaccines Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on inactivated polio and rabies vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for inactivated polio and rabies vaccines ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The inactivated polio and rabies vaccines market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Product Type: Inactivated Polio Vaccine; Inactivated Rabies Vaccine
2) By Method Of Inactivation: Solvent Detergent Method; Radiation Method; pH Concentration; Heat Inactivation; Other Method Of Inactivations
3) By Distribution Channel: Government; Private
4) By Application: Pediatrics; Adults
Subsegments:
1) By Inactivated Polio Vaccine: Injectable Inactivated Polio Vaccine; Oral Inactivated Polio Vaccine
2) By Inactivated Rabies Vaccine: Injectable Inactivated Rabies Vaccine; Intradermal Inactivated Rabies Vaccine
Companies Mentioned: Merck & Co Inc.; Sanofi S.A.; LG Chem Ltd.; Boehringer Ingelheim International GmbH; Sinovac Biotech
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r35443

1. Executive Summary

2. Inactivated Polio And Rabies Vaccines Market Characteristics

3. Inactivated Polio And Rabies Vaccines Market Trends And Strategies

4. Inactivated Polio And Rabies Vaccines Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Inactivated Polio And Rabies Vaccines Growth Analysis And Strategic Analysis Framework

5.1. Global Inactivated Polio And Rabies Vaccines PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Inactivated Polio And Rabies Vaccines Market Growth Rate Analysis
5.4. Global Inactivated Polio And Rabies Vaccines Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Inactivated Polio And Rabies Vaccines Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Inactivated Polio And Rabies Vaccines Total Addressable Market (TAM)

6. Inactivated Polio And Rabies Vaccines Market Segmentation

6.1. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Polio Vaccine
Inactivated Rabies Vaccine
6.2. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Solvent Detergent Method
Radiation Method
pH Concentration
Heat Inactivation
Other Method Of Inactivations
6.3. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Government
Private
6.4. Global Inactivated Polio And Rabies Vaccines Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pediatrics
Adults
6.5. Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Polio Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Inactivated Polio Vaccine
Oral Inactivated Polio Vaccine
6.6. Global Inactivated Polio And Rabies Vaccines Market, Sub-Segmentation Of Inactivated Rabies Vaccine, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Injectable Inactivated Rabies Vaccine
Intradermal Inactivated Rabies Vaccine

7. Inactivated Polio And Rabies Vaccines Market Regional And Country Analysis

7.1. Global Inactivated Polio And Rabies Vaccines Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Inactivated Polio And Rabies Vaccines Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Inactivated Polio And Rabies Vaccines Market

8.1. Asia-Pacific Inactivated Polio And Rabies Vaccines Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Inactivated Polio And Rabies Vaccines Market

9.1. China Inactivated Polio And Rabies Vaccines Market Overview
9.2. China Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Inactivated Polio And Rabies Vaccines Market

10.1. India Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Inactivated Polio And Rabies Vaccines Market

11.1. Japan Inactivated Polio And Rabies Vaccines Market Overview
11.2. Japan Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Inactivated Polio And Rabies Vaccines Market

12.1. Australia Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Inactivated Polio And Rabies Vaccines Market

13.1. Indonesia Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Inactivated Polio And Rabies Vaccines Market

14.1. South Korea Inactivated Polio And Rabies Vaccines Market Overview
14.2. South Korea Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Inactivated Polio And Rabies Vaccines Market

15.1. Western Europe Inactivated Polio And Rabies Vaccines Market Overview
15.2. Western Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Inactivated Polio And Rabies Vaccines Market

16.1. UK Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Inactivated Polio And Rabies Vaccines Market

17.1. Germany Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Inactivated Polio And Rabies Vaccines Market

18.1. France Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Inactivated Polio And Rabies Vaccines Market

19.1. Italy Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Inactivated Polio And Rabies Vaccines Market

20.1. Spain Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Inactivated Polio And Rabies Vaccines Market

21.1. Eastern Europe Inactivated Polio And Rabies Vaccines Market Overview
21.2. Eastern Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Inactivated Polio And Rabies Vaccines Market

22.1. Russia Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Inactivated Polio And Rabies Vaccines Market

23.1. North America Inactivated Polio And Rabies Vaccines Market Overview
23.2. North America Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Inactivated Polio And Rabies Vaccines Market

24.1. USA Inactivated Polio And Rabies Vaccines Market Overview
24.2. USA Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Inactivated Polio And Rabies Vaccines Market

25.1. Canada Inactivated Polio And Rabies Vaccines Market Overview
25.2. Canada Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Inactivated Polio And Rabies Vaccines Market

26.1. South America Inactivated Polio And Rabies Vaccines Market Overview
26.2. South America Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Inactivated Polio And Rabies Vaccines Market

27.1. Brazil Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Inactivated Polio And Rabies Vaccines Market

28.1. Middle East Inactivated Polio And Rabies Vaccines Market Overview
28.2. Middle East Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Inactivated Polio And Rabies Vaccines Market

29.1. Africa Inactivated Polio And Rabies Vaccines Market Overview
29.2. Africa Inactivated Polio And Rabies Vaccines Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Inactivated Polio And Rabies Vaccines Market, Segmentation By Method Of Inactivation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Inactivated Polio And Rabies Vaccines Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Inactivated Polio And Rabies Vaccines Market Competitive Landscape And Company Profiles

30.1. Inactivated Polio And Rabies Vaccines Market Competitive Landscape
30.2. Inactivated Polio And Rabies Vaccines Market Company Profiles
- 30.2.1. Merck & Co Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. LG Chem Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Sinovac Biotech Overview, Products and Services, Strategy and Financial Analysis

31. Inactivated Polio And Rabies Vaccines Market Other Major And Innovative Companies

31.1. Zoetis Inc.
31.2. Cadila Pharmaceuticals
31.3. Zydus Lifesciences Limited
31.4. Biological E. Limited
31.5. Serum Institute of India (SII)
31.6. Indian Immunologicals Limited (IIL)
31.7. Instituto Butantan
31.8. Valneva SE
31.9. Bio Farma
31.10. Bharat Biotech
31.11. Bilthoven Biologicals
31.12. Panacea Biotec
31.13. Batavia Biosciences
31.14. Hilleman Laboratories
31.15. China National Pharmaceutical Group Co Ltd.

32. Global Inactivated Polio And Rabies Vaccines Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Inactivated Polio And Rabies Vaccines Market

34. Recent Developments In The Inactivated Polio And Rabies Vaccines Market

35. Inactivated Polio And Rabies Vaccines Market High Potential Countries, Segments and Strategies

35.1 Inactivated Polio And Rabies Vaccines Market In 2029 - Countries Offering Most New Opportunities
35.2 Inactivated Polio And Rabies Vaccines Market In 2029 - Segments Offering Most New Opportunities
35.3 Inactivated Polio And Rabies Vaccines Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer